First Trust Advisors LP boosted its position in Innophos Holdings, Inc. (NASDAQ:IPHS) by 60.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 37,775 shares of the specialty chemicals company’s stock after acquiring an additional 14,173 shares during the quarter. First Trust Advisors LP owned 0.19% of Innophos worth $1,858,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in IPHS. Public Employees Retirement System of Ohio increased its stake in Innophos by 5.9% in the second quarter. Public Employees Retirement System of Ohio now owns 2,824 shares of the specialty chemicals company’s stock valued at $124,000 after acquiring an additional 157 shares during the last quarter. Pacad Investment Ltd. increased its stake in Innophos by 19.5% in the second quarter. Pacad Investment Ltd. now owns 4,900 shares of the specialty chemicals company’s stock valued at $215,000 after acquiring an additional 800 shares during the last quarter. State of Alaska Department of Revenue increased its stake in Innophos by 44.6% in the second quarter. State of Alaska Department of Revenue now owns 5,508 shares of the specialty chemicals company’s stock valued at $240,000 after acquiring an additional 1,698 shares during the last quarter. GHP Investment Advisors Inc. increased its stake in Innophos by 35.5% in the second quarter. GHP Investment Advisors Inc. now owns 5,599 shares of the specialty chemicals company’s stock valued at $245,000 after acquiring an additional 1,468 shares during the last quarter. Finally, Wedge Capital Management L L P NC increased its stake in Innophos by 25.1% in the second quarter. Wedge Capital Management L L P NC now owns 5,669 shares of the specialty chemicals company’s stock valued at $249,000 after acquiring an additional 1,136 shares during the last quarter. 94.35% of the stock is currently owned by institutional investors and hedge funds.

Innophos Holdings, Inc. (NASDAQ:IPHS) opened at $44.72 on Tuesday. The company has a market capitalization of $869.04, a price-to-earnings ratio of 18.09 and a beta of 0.88. The company has a debt-to-equity ratio of 0.83, a current ratio of 2.86 and a quick ratio of 1.49. Innophos Holdings, Inc. has a 12 month low of $41.66 and a 12 month high of $58.22.

Innophos (NASDAQ:IPHS) last released its earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.78 EPS for the quarter, beating the Zacks’ consensus estimate of $0.72 by $0.06. The business had revenue of $184.00 million for the quarter, compared to analysts’ expectations of $179.33 million. Innophos had a return on equity of 13.90% and a net margin of 6.19%. The firm’s revenue was down 1.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.69 earnings per share. equities analysts forecast that Innophos Holdings, Inc. will post 2.5 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 6th. Shareholders of record on Friday, November 17th will be given a dividend of $0.48 per share. The ex-dividend date of this dividend is Thursday, November 16th. This represents a $1.92 annualized dividend and a yield of 4.29%. Innophos’s payout ratio is 88.48%.

A number of research analysts recently commented on the company. Zacks Investment Research cut Innophos from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 4th. KeyCorp reissued a “hold” rating on shares of Innophos in a research note on Wednesday, November 1st.

ILLEGAL ACTIVITY WARNING: “Innophos Holdings, Inc. (IPHS) Shares Bought by First Trust Advisors LP” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/11/28/innophos-holdings-inc-iphs-shares-bought-by-first-trust-advisors-lp.html.

Innophos Company Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).

Institutional Ownership by Quarter for Innophos (NASDAQ:IPHS)

Receive News & Stock Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related stocks with our FREE daily email newsletter.